You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

opdivo

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma Trial in Australia (Opdivo)

Active, not recruiting
  • Follicular Lymphoma
  • Opdivo
  • Ballarat, Victoria, Australia
  • +4 more
Jan 30, 2023

Advanced Melanoma Trial in Belarus, Russian Federation (BCD-263, Opdivo)

Recruiting
  • Advanced Melanoma
  • Minsk, Belarus
  • +29 more
Nov 2, 2023

Lenvatinib Combined Anti-PD1 Antibody for Advanced

Completed
  • Hepatocellular Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Second Affiliated Hospital of Guangzhou Medical University
Jul 8, 2022

Uveal Melanoma Trial in Scottsdale (Novocure Optune, Opdivo, Yervoy)

Recruiting
  • Uveal Melanoma
  • Novocure Optune
  • +2 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
Mar 21, 2022

Nasopharyngeal Cancer Trial in Poland (Opdivo)

Not yet recruiting
  • Nasopharyngeal Cancer
  • Opdivo
  • Białystok, Poland
  • +3 more
Jun 21, 2021

NSCLC Trial in Birmingham, Tampa (Carotuximab (TRC105), OPDIVO)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Carotuximab (TRC105)
  • OPDIVO
  • Birmingham, Alabama
  • +1 more
Jun 11, 2020

Metastatic Solid Tumor Cancer, Recurrent Head Neck Cancer Trial in Houston (Ad-P53, Xeloda, Keytruda)

Terminated
  • Metastatic Solid Tumor Cancer
  • Recurrent Head and Neck Cancer
  • Houston, Texas
    MD Anderson Cancer Center
May 30, 2020